Quick Answer
DEXCOM INC reported Net Income Loss of $836.30 million for the year ending 2025.
- DEXCOM INC showed an increase of +45.1% in Net Income Loss from 2024 to 2025.
- This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$6.00 million | Q4 2013: -$2.60 million | Q1 2014: -$12.50 million | Q2 2014: -$6.00 million | Q3 2014: -$5.20 million | Q4 2014: $1.30 million | Q1 2015: -$12.90 million | Q2 2015: -$3.70 million | Q3 2015: -$42.50 million | Q4 2015: $1.50 million | Q1 2016: -$19.20 million | Q2 2016: -$20.20 million | Q3 2016: -$18.80 million | Q4 2016: -$7.40 million | Q1 2017: -$41.70 million | Q2 2017: $2.90 million | Q3 2017: -$2.00 million | Q4 2017: -$9.40 million | Q1 2018: -$24.20 million | Q2 2018: $30.20 million | Q3 2018: $46.60 million | Q4 2018: -$179.70 million | Q1 2019: -$26.90 million | Q2 2019: -$10.50 million | Q3 2019: $45.80 million | Q4 2019: $92.70 million | Q1 2020: $19.90 million | Q2 2020: $46.30 million | Q3 2020: $72.20 million | Q1 2021: $56.50 million | Q2 2021: $78.40 million | Q3 2021: $87.30 million | Q1 2022: $97.30 million | Q2 2022: $50.90 million | Q3 2022: $101.20 million | Q1 2023: $48.60 million | Q2 2023: $115.90 million | Q3 2023: $120.70 million | Q1 2024: $146.40 million | Q2 2024: $143.50 million | Q3 2024: $134.60 million | Q1 2025: $105.40 million | Q2 2025: $179.80 million | Q3 2025: $283.80 million.
- Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Net Income Loss has grown by 1,662.5%.
- Historical annual values: Fiscal year 2025: $836.30 million | Fiscal year 2024: $576.20 million | Fiscal year 2023: $541.50 million | Fiscal year 2022: $341.20 million | Fiscal year 2021: $216.90 million | Fiscal year 2020: $549.70 million | Fiscal year 2019: $101.10 million | Fiscal year 2018: -$127.10 million | Fiscal year 2017: -$50.20 million | Fiscal year 2016: -$65.60 million | Fiscal year 2015: -$57.60 million | Fiscal year 2014: -$22.40 million | Fiscal year 2013: -$29.80 million | Fiscal year 2012: -$54.50 million | Fiscal year 2011: -$44.70 million | Fiscal year 2010: -$55.20 million | Fiscal year 2009: -$53.52 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: